Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
15:48:23 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.6000 USD | -27.18% |
|
+10.20% | -11.79% |
| Market Cap | 1.98M 1.7M 1.61M 1.46M 2.74M 189M 2.76M 19.15M 7.36M 96M 7.42M 7.26M 304M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -878K -757K -716K -649K -1.22M -83.88M -1.22M -8.5M -3.27M -42.63M -3.3M -3.22M -135M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -27.18% | ||
| 1 week | +10.20% | ||
| Current month | +32.74% | ||
| 1 month | +135.20% | ||
| 3 months | +100.00% | ||
| 6 months | +116.22% | ||
| Current year | -11.79% |
| 1 week | 0.5 |  | 0.9 |
| 1 month | 0.26 | | 0.9 |
| Current year | 0.15 | | 0.9 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 64.27 |
| 5 years | 0.15 | | 2,081.25 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/2/26 | Free | Company | 111,209 | 3.4934% | ||
| 3/31/25 | Free | Company | 33,724 | 1.6419% | ||
| 12/31/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.18% | +10.20% | -30.23% | -98.89% | 1.98M | |
| -2.11% | -1.68% | +44.52% | +95.15% | 66.93B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 61.97B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 28.27B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.59B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.3B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.41B | |
| -3.03% | -2.29% | +185.12% | +334.07% | 16.77B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.18B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 13.91B | |
| Average | -3.54% | -2.09% | +29.50% | +141.60% | 27.03B | |
| Weighted average by Cap. | -0.84% | -3.06% | +33.46% | +133.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.21 1.15 1.04 1.95 134.14 1.96 13.6 5.23 68.17 5.27 5.16 215.59 |
| Net income | -11.65M -10.05M -9.51M -8.62M -16.16M -1.11B -16.26M -113M -43.39M -566M -43.76M -42.79M -1.79B | -2.91M -2.51M -2.37M -2.15M -4.03M -278M -4.06M -28.17M -10.83M -141M -10.92M -10.68M -447M |
| Net Debt | -2.59M -2.24M -2.12M -1.92M -3.6M -248M -3.62M -25.12M -9.66M -126M -9.74M -9.53M -398M | -2.86M -2.46M -2.33M -2.11M -3.96M -273M -3.98M -27.65M -10.63M -139M -10.72M -10.49M -438M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$0.6000 | -27.18% | 30,817 |
| 26-09-10 | US$0.8240 | +26.42% | 37,513 |
| 26-09-09 | US$0.6518 | +20.70% | 7,408 |
| 26-09-08 | US$0.5400 | -0.82% | 5,756 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
